Back

Uninterrupted and minimally-interrupted direct oral anticoagulant therapy in patients undergoing catheter ablation for atrial fibrillation. An updated meta-analysis

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 1 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mate Ottoffy

University of Pecs, Pecs (Hungary)

13 More presentations in this session

Presentation thumbnail
Associate Professor T. Novikova (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Doctor L. Bergamaschi (Bologna, IT)
Abstract Slides
Presentation thumbnail
Ms I. Palau (London, GB)
Abstract
Presentation thumbnail
Doctor Y. Gue (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Professor P. Hjemdahl (Stockholm, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 1

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis
1 September 2025
thumbnail
Congress Presentation
Direct oral anticoagulants compared to vitamin K-antagonists in patients with left ventricular thrombus
27 August 2022
thumbnail
Congress Presentation
Interrupted or uninterrupted direct oral anticoagulants for atrial aibrillation ablation which is the best strategy insights from a network meta-analysis
30 August 2025
thumbnail
Congress Session
Arrhythmias during pregnancy: help and not harm
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources